Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY® (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022
Medication labelWhy this: Advisory · dailymed-prescription
AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults.
- generic_name
- dextromethorphan hydrobromide, bupropion hydrochloride
- product_names
- dextromethorphan hydrobromide, bupropion hydrochloride
- ndc
- 81968-045, 81968-045-30, 81968-045-14, 81968-045-60, 81968-045-31
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en